Literature DB >> 29482300

Unicompartmental Knee Arthroplasty.

Kyung Tae Kim1.   

Abstract

Entities:  

Year:  2018        PMID: 29482300      PMCID: PMC5853177          DOI: 10.5792/ksrr.18.014

Source DB:  PubMed          Journal:  Knee Surg Relat Res        ISSN: 2234-0726


× No keyword cloud information.
Unicompartmental knee arthroplasty (UKA) is a surgical procedure that selectively replaces only the damaged compartment of the knee for the treatment of osteoarthritis. It has specific and narrow indications, and treatment success is highly dependent on the surgeon’s skill and implant selection. In addition, it is technically difficult to perform, early failure rates are relatively high, and the long-term survivorship of UKA has not yet been extensively studied1,2). The theme of this issue of the Knee Surgery & Related Research (KSRR) is UKA. The current issue contains three original articles on this theme. In one article, Kim et al. described the long-term clinical results of UKA in patients younger than 60 years of age. Another article by Cho et al. focused on the design of implant and surgical technique of UKA. The last article by Ryu et al. compared the clinical and radiographic outcomes of HTO and UKA in relatively young patients with unicompartmental arthritis of the knee. The traditional indications for UKA include degenerative arthritis of the knee affecting one compartment, >60 years of age, body weight <82 kg (180 lb), low-demand for activities, range of motion ≥90°, flexion contracture ≤5°, angular deformity <15°, and absence of symptoms and signs of inflammatory arthritis3). However, the indications have continued to expand with recent advancements in surgical techniques and implant designs. As a result, UKA is currently considered a viable option in most patients regardless of age, activity level, and weight4,5). Although the indications for UKA considerably overlap with those for HTO, UKA is generally used to treat severe osteoarthritis (grade 3 or 4), whereas HTO is recommended in the presence of an anterior cruciate ligament injury or anteroposterior instability6). In this issue of KSRR, Ryu et al. reviewed the indications and clinical outcomes of UKA and HTO and compared the short-term clinical outcomes of the two procedures for severe arthritis with kissing lesions. Implants for UKA can be largely categorized as mobile-bearing and fixed-bearing types. Implant selection is dependent on the surgeon’s preference, indications, and surgical technique, and the optimal implant design for excellent clinical outcome has not been fully elucidated7,8). Although different surgical techniques are employed according to the implant design and surgical instrument used in UKA, the surgical principles are similar. In the past, the conventional open approach necessitated complete exposure of the knee joint for UKA. By contrast, minimally invasive techniques are most commonly used in recent UKAs, which demands proper use of instruments and training to obviate failure4,9). The most important factors that determine the success of UKA are limb alignment, ligament balance, and implant fixation10). In this issue, Cho et al. recommended increasing the flexion angle of the femoral component for greater knee flexion after UKA. However, it should also be taken into consideration that recent femoral components are already designed to provide an increased flexion angle compared to previous designs. Excellent clinical outcomes of UKA have been demonstrated in a number of publications, such as alleviation of pain, restoration of range of motion, deformity correction, and improvement in knee scores and function scores. In particular, Kozinn and Scott3) reported that UKA in elderly patients (>60 years) with degenerative arthritis provided excellent clinical outcomes when performed with strict patient selection criteria, which has since been confirmed in numerous studies5,11). Excellent implant survivorship has also been demonstrated in various recent studies, which attribute it to accurate selection of indications, continuous improvement of implant designs, refinement of surgical instrument, and advances in surgical techniques5,11). Still, there is no established consensus on the long-term survivorship of UKA, which greatly varies according to the implant design and surgeon’s experience. In general, the longevity of UKA has been considered to be inferior to that of TKA1,12). On the clinical outcomes of UKA in young patients (≤60 years), conflicting results have been reported in the literature. In recent studies, there is a growing tendency of showing promising outcomes of UKA comparable to those of TKA in young patients1,13). In 2017, Kim et al.14) reported successful mid-term outcomes of UKA obtained in less than 60-year-old young patients. The current issue also presents a study on the long-term clinical results of UKA performed in patients younger than 60 years of age. The significance of the study is that all the cases were followed up for the minimum 10-year postoperative period. In addition, it was a single center study involving a relatively large study population. Complications that can occur following UKA include polyethylene wear and breakage, aseptic loosening, bearing dislocation, periprosthetic fracture, progression of arthritis to the contralateral compartment, infection, ankylosis of the knee, and persistent pain2). Early failure after UKA is strongly related to the surgical technique. Most complications occur within 1 or 2 years after UKA, which is mostly attributable to inappropriate patient selection or inadequate surgical technique. Therefore, appropriate patient selection, acquisition of precise surgical skills, and experience are required for prevention of such complications11). One recent article published in KSRR in 201615) is worth considering. It reviewed the causes and types of complications (n=89) that occurred following UKA (n=1,576) and investigated optimal treatment methods. UKA has demonstrated excellent efficacy in terms of clinical outcomes, patient satisfaction, and implant survivorship. Therefore, the popularity of UKA is expected to increase over time as an effective treatment method for degenerative arthritis involving one compartment of the knee. However, considering the unresolved controversies surrounding the indications of the procedure, such as patient’s age, and the long-term implant survivorship, further long-term research is warranted.
  14 in total

1.  Mobile- versus fixed-bearing unicompartmental knee arthroplasty.

Authors:  Richard D Scott
Journal:  Instr Course Lect       Date:  2010

2.  Making your next unicompartmental knee arthroplasty last: three keys to success.

Authors:  Leo A Whiteside
Journal:  J Arthroplasty       Date:  2005-06       Impact factor: 4.757

3.  A prospective analysis of Oxford phase 3 unicompartmental knee arthroplasty.

Authors:  Kyung Tae Kim; Song Lee; Hoon Seok Park; Kun Ho Cho; Kwan Soo Kim
Journal:  Orthopedics       Date:  2007-05       Impact factor: 1.390

4.  Does new instrumentation improve radiologic alignment of the Oxford® medial unicompartmental knee arthroplasty?

Authors:  Ki-Mo Jang; Hong Chul Lim; Seung-Beom Han; Chandong Jeong; Seul-Gi Kim; Ji-Hoon Bae
Journal:  Knee       Date:  2017-03-19       Impact factor: 2.199

5.  Unicompartmental knee replacement provides early clinical and functional improvement stabilizing over time.

Authors:  Alfredo Schiavone Panni; Michele Vasso; Simone Cerciello; Alessandro Felici
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-07-12       Impact factor: 4.342

Review 6.  Unicompartmental mobile-bearing knee arthroplasty.

Authors:  Roger H Emerson
Journal:  Instr Course Lect       Date:  2005

7.  Unicompartmental knee arthroplasty in patients aged less than 65.

Authors:  Annette W-Dahl; Otto Robertsson; Lars Lidgren; Lisa Miller; David Davidson; Stephen Graves
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

8.  A mid term comparison of open wedge high tibial osteotomy vs unicompartmental knee arthroplasty for medial compartment osteoarthritis of the knee.

Authors:  Ryohei Takeuchi; Yusuke Umemoto; Masato Aratake; Haruhiko Bito; Izumi Saito; Ken Kumagai; Yohei Sasaki; Yasushi Akamatsu; Hiroyuki Ishikawa; Tomihisa Koshino; Tomoyuki Saito
Journal:  J Orthop Surg Res       Date:  2010-08-30       Impact factor: 2.359

Review 9.  Unicompartmental knee arthroplasty: a review of literature.

Authors:  Bernardino Saccomanni
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

10.  The clinical outcome of minimally invasive Phase 3 Oxford unicompartmental knee arthroplasty: a 15-year follow-up of 1000 UKAs.

Authors:  H Pandit; T W Hamilton; C Jenkins; S J Mellon; C A F Dodd; D W Murray
Journal:  Bone Joint J       Date:  2015-11       Impact factor: 5.082

View more
  5 in total

1.  Poor Clearance of Free Hemoglobin Due to Lower Active Haptoglobin Availability is Associated with Osteoarthritis Inflammation.

Authors:  Ashish Sarkar; Vijay Kumar; Rajesh Malhotra; Hemant Pandit; Elena Jones; Frederique Ponchel; Sagarika Biswas
Journal:  J Inflamm Res       Date:  2021-03-18

2.  [Research progress in unicompartmental knee arthroplasty].

Authors:  Dong Wu; Minzhi Yang; Zheng Cao; Xiangpeng Kong; Yi Wang; Renwen Guo; Wei Chai
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-02-15

3.  What is the effect of supervised rehabilitation regime vs. self-management instruction following unicompartmental knee arthroplasty? - a pilot study in two cohorts.

Authors:  Adam Omari; Lina Holm Ingelsrud; Thomas Quaade Bandholm; Susanne Irene Lentz; Anders Troelsen; Kirill Gromov
Journal:  J Exp Orthop       Date:  2021-06-09

4.  Gait comparison of unicompartmental knee arthroplasty and total knee arthroplasty during level walking.

Authors:  Kyung-Wook Nha; Oog-Jin Shon; Byung-Sic Kong; Young-Soo Shin
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

5.  Survival of medial versus lateral unicompartmental knee arthroplasty: A meta-analysis.

Authors:  Seung-Beom Han; Sang-Soo Lee; Kyoung-Ho Kim; Jung-Taek Im; Phil-Sun Park; Young-Soo Shin
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.